Regulation of endothelial progenitor cell function by micrornas.
E Goretti1, D R Wagner, Y Devaux
1Laboratory of Cardiovascular Research, Centre de Recherche Public de la Santé, (CRP-Santé) Luxembourg, Luxembourg - yvan.devaux@crp-sante.lu.
Minerva Cardioangiologica
|November 21, 2013
Summary
Endothelial progenitor cells (EPCs) aid heart repair after injury. MicroRNAs (miRNAs) show promise in enhancing EPC function for improved cardiac regeneration therapies.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Molecular Biology
Background:
- Endothelial progenitor cells (EPCs) are crucial for cardiac repair post-injury, promoting revascularization.
- Despite research, EPC phenotype and function remain debated, limiting therapeutic benefits from cell injections.
- MicroRNAs (miRNAs) are key regulators of gene expression involved in cardiac pathophysiology.
Purpose of the Study:
- To review the role of EPCs in cardiovascular disease.
- To summarize current knowledge on miRNA involvement in EPC biology.
- To explore how miRNAs can enhance EPCs for cardiac repair.
Main Methods:
- Literature review of EPC function in cardiovascular disease.
- Synthesis of research on miRNA roles within EPCs.
- Discussion of miRNA-based strategies for improving EPC therapeutic potential.
Main Results:
- EPCs contribute to cardiac repair, but their precise mechanisms require further elucidation.
- miRNAs significantly influence EPC characteristics and functions.
- Targeting miRNAs offers a potential avenue to boost EPC regenerative capacity.
Conclusions:
- Understanding miRNA-EPC interactions is vital for advancing cardiac regenerative medicine.
- Modulating miRNAs could enhance the efficacy of EPC-based therapies for heart repair.
- Further research into miRNA modulation is warranted to optimize EPC function in cardiovascular disease treatment.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
01:01Regulation of Hematopoietic Stem Cells
3.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
01:22MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
01:22MicroRNAs
9.8K
9.8K